<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Patel S</submitter><funding>HSRD VA</funding><funding>US Department of Veterans Affairs</funding><pagination>467-479</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12844147</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(3)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Chronic kidney disease (CKD) is defined by the KDIGO (Kidney Disease: Improving Global Outcomes) guideline as abnormal kidney structure or function, present for >3 months, with implications for health. KDIGO-defined CKD is associated with poor outcomes in patients with heart failure (HF). Less is known about whether these associations vary by left ventricular ejection fraction.&lt;h4>Objectives&lt;/h4>This study aims to determine the prevalence and outcomes of KDIGO-defined CKD in heart failure with preserved ejection fraction (HFpEF), heart failure with mildly reduced ejection fraction (HFmrEF), and heart failure with reduced ejection fraction (HFrEF).&lt;h4>Methods&lt;/h4>Of the 1,446,053 veterans with an HF diagnosis (1991-2017) in the national Veterans Affairs electronic health </pubmed_abstract><journal>JACC. Heart failure</journal><pubmed_title>Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.</pubmed_title><pmcid>PMC12844147</pmcid><funding_grant_id>SDR 02-237</funding_grant_id><funding_grant_id>I01 HX002422</funding_grant_id><pubmed_authors>Fonarow GC</pubmed_authors><pubmed_authors>Heidenreich PA</pubmed_authors><pubmed_authors>Morgan CJ</pubmed_authors><pubmed_authors>Zeng-Treitler Q</pubmed_authors><pubmed_authors>Ahmed AA</pubmed_authors><pubmed_authors>Allman RM</pubmed_authors><pubmed_authors>Raman VK</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Sheriff HM</pubmed_authors><pubmed_authors>Bakris G</pubmed_authors><pubmed_authors>Wu WC</pubmed_authors><pubmed_authors>Moore H</pubmed_authors><pubmed_authors>Anker SD</pubmed_authors><pubmed_authors>Deedwania P</pubmed_authors><pubmed_authors>Rangaswami J</pubmed_authors><pubmed_authors>Patel S</pubmed_authors><pubmed_authors>Butler J</pubmed_authors><pubmed_authors>Lam PH</pubmed_authors><pubmed_authors>Ahmed A</pubmed_authors><pubmed_authors>Faselis C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF.</name><description>&lt;h4>Background&lt;/h4>Chronic kidney disease (CKD) is defined by the KDIGO (Kidney Disease: Improving Global Outcomes) guideline as abnormal kidney structure or function, present for >3 months, with implications for health. KDIGO-defined CKD is associated with poor outcomes in patients with heart failure (HF). Less is known about whether these associations vary by left ventricular ejection fraction.&lt;h4>Objectives&lt;/h4>This study aims to determine the prevalence and outcomes of KDIGO-defined CKD in heart failure with preserved ejection fraction (HFpEF), heart failure with mildly reduced ejection fraction (HFmrEF), and heart failure with reduced ejection fraction (HFrEF).&lt;h4>Methods&lt;/h4>Of the 1,446,053 veterans with an HF diagnosis (1991-2017) in the national Veterans Affairs electronic health </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-07-16T23:23:56.647Z</modification><creation>2026-07-12T03:11:10.386Z</creation></dates><accession>S-EPMC12844147</accession><cross_references><pubmed>39918536</pubmed><doi>10.1016/j.jchf.2024.11.007</doi></cross_references></HashMap>